Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients

Clinical Neurophysiology

Volumn 123, Issue 5, 2012, Pages 883-891

  Cho, Jounhong Ryan ^a,b   Koo, Dae Lim ^a   Joo, Eun Yeon ^a   Yoon, So Mi ^a   Ju, Eunji ^c   Lee, James ^d   Kim, Dae Young ^a   Hong, Seung Bong ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antiepileptic drugs; Cognitive function; EEG; Levetiracetam; Quantitative analysis

Indexed keywords

ETIRACETAM;

ADULT; ARTICLE; ATTENTION; BRAIN FUNCTION; BRAIN REGION; CLINICAL ARTICLE; COGNITION; DISEASE CONTROL; DRUG DOSE TITRATION; DRUG EFFECT; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; EPILEPSY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; LANGUAGE; MALE; MENTAL PERFORMANCE; MONOTHERAPY; NEUROPSYCHOLOGICAL TEST; OCCIPITAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; TREATMENT DURATION; WORKING MEMORY;

ADOLESCENT; ADULT; ANTICONVULSANTS; BRAIN MAPPING; BRAIN WAVES; COGNITION; ELECTROENCEPHALOGRAPHY; EPILEPSY; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; FOURIER ANALYSIS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PIRACETAM; RETROSPECTIVE STUDIES; VERBAL LEARNING; YOUNG ADULT;

EID: 84858746560     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2011.09.012     Document Type: Article

References (48)

1. Angelakis E., Lubar J.F., Stathopoulou S., Kounios J. Peak alpha frequency: an electroencephalographic measure of cognitive preparedness. Clin Neurophysiol 2004, 115:887-897.
2. Berkovic S.F., Knowlton R.C., Leroy R.F., Shiemann J., Falter U. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007, 669:1751-1760.
3. Besser R., Hornung K., Theisohn M., Rothacher G., Kramer G. EEG changes in patients during the introduction of carbamazepine. Electroencephalogr Clin Neurophysiol 1992, 83:19-23.
4. Clemens B., Menes A., Nagy Z. Objective assessment of neurotoxicity while shifting from carbamazepine to oxcarbazepine. Acta Neurol Scand 2004, 109:324-329.
5. Clemens B., Menes A., Piros P., Bessenyei M., Altmann A., Jerney J., et al. Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings. Epilepsy Res 2006, 70:190-199.
6. Corsi P.M. Human memory and the medial temporal region of the brain. Dissertation Abstr Int 1972, 34:891B. (University Microfilms No. AAI05-77717).
7. Duncan J.S., Smith S.J., Forster A. Effects of the removal of phenytoin, carbamazepine and valproate on cognitive function. Epilepsia 1989, 30:590-596.
8. Frost J.D., Hrachovy R.A., Glaze D.G., Rettig G.M. Alpha rhythm slowing during initiation of carbamazepine therapy: implications for future cognitive performance. J Clin Neurophysiol 1995, 12:57-63.
9. Gambardella A., Labate A., Colosimo E., Ambrosio R., Quattrone A. Monotherapy for partial epilepsy: focus on levetiracetam. Neuropsychitr Dis Treat 2008, 4:33-38.
10. Gevins A., Smith M.E., McEvoy L.K. Tracking the cognitive pharmacodynamics of psychoactive substances with combinations of behavioral and neurophysiological measures. Neuropsychopharmacology 2002, 26:27-39.
11. Gomer B., Wagner K., Frings L., Saar J., Carius A., Harle M., et al. The influence of antiepileptic drugs on cognition: A comparison of levetiracetam with topiramate. Epilepsy Behav 2007, 10:486-494.
12. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., Curtiss G. Wisconsin card sorting test manual revised and expanded 1993, Psychological Assessment Resources, Inc., Lutz, FL.
13. Helmstaedter C., Witt J.A. The effects of levetiracetam on cognition: a non-interventional surveillance study. Epilepsy Behav 2008, 13:642-649.
14. Ingvar E., Sjolund B., Ardo A. Correlation between dominant EEG frequency, cerebral oxygen uptake, and blood flow. Electroencephalogr Clin Neurophysiol 1976, 41:268-276.
15. Joo E.Y., Tae W.S., Hong S.B. Regional effects of lamotrigine on cerebral glucose metabolism in idiopathic generalized epilepsy. Arch Neurol 2006, 63:1282-1286.
16. Joo E.Y., Hong S.B., Tae W.S., Han S.J., Seo D.W., Lee K.H., et al. Effect of lamotrigine on cerebral blood flow in patients with idiopathic generalised epilepsy. Eur J Nucl Med Mol Imaging 2006, 33:724-729.
17. Jun Y.S., Suh B.Y., Lee C.W. Instructions for KWIS 1963, Jung-Ang Institute of Education, Seoul.
18. Jung K.Y., Cho J.W., Joo E.Y., Kim S.H., Choi K.M., Chin J., et al. Cognitive effects of topiramate revealed by standardised low-resolution brain electromagnetic tomography (sLORETA) of event-related potentials. Clin Neurophysiol 2010, 121:1494-1501.
19. Kang Y.W., Na D.L. Seoul neuropsychological screening battery 2003, Human Brain Research & Consulting, Seoul.
20. Kim J., Kang Y. Korean-California verbal learning test 1997, Special Education, Seoul.
21. Kim H.H., Na D.L. Korean-Boston naming test (K-BNT) 1997, Hakjisa, Seoul.
22. Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance. A review and analysis. Brain Res Rev 1999, 29:169-195.
23. Lamberty Y., Margineanu D.G., Klitgaard H. Absence of negative impact of levetiracetam on cognitive function and memory in normal and amygdala-kindled rats. Epilepsy Behav 2000, 1:333-342.
24. Lee J.H., Kang Y.W., Na D.L. Efficiencies of the Stroop interference indexes in healthy older adults and dementia patients. Korean J Clin Psychol 2000, 19:807-818.
25. Marciani M.G., Stanzione P., Mattia D., Spanedda F., Bassetti M.A., Maschio M., et al. Lamotrigine add-on therapy in focal epilepsy: electroencephalographic and neuropsychological evaluation. Clin Neuropharmacol 1998, 21:41-47.
26. Marciani M.G., Spanedda F., Mattia D. Neurophysiologic and neuropsychologic profiles of lamotrigine in epilepsy. Clin Neuropharmacol 1999, 22:159-163.
27. Meador K.J., Loring D.W., Abney O.L., Allen M.E., Moore E.E., Zamrini E.Y., et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 1993, 34:153-157.
28. Meador K.J., Gevins A., Loring D.W., McEvoy L.K., Ray P.G., Smith M.E., et al. Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. Neurology 2007, 69:2076-2084.
29. Mecarelli O., Piacenti A., Pultino P., Vicenzini E., Rizzo C., Rinalduzzi S., et al. Clinical and electroencephalographic effects of topiramate in patients with epilepsy and healthy volunteers. Clin Neuropharmacol 2001, 24:284-289.
30. Mecarelli O., Vicenzini E., Pulitano P., Vanacore N., Romolo F.S., Di Piero V., et al. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. Ann Pharmacothr 2004, 38:1816-1822.
31. Meyers J.E., Meyers K.R. Rey complex figure test and recognition trial 1995, Psychological assessment resources, Inc., Lutz, FL.
32. Michel C.M., Lehmann D., Henggeler B., Brandeis D. Localization of the sources of EEG delta, theta, alpha and beta frequency bands using the FFT dipole approximation. Electroencephalogr Clin Neurophysiol 1992, 82:38-44.
33. Mitra S.K. Digital signal processing: a computer-based approach 1998, McGraw-Hill, New York.
34. Neufeld M.Y., Kogan E., Chistik V., Korczyn A.D. Comparison of the effects of vigabatrin, lamotrigine and topiramate on quantitative EEG in patients with epilepsy. Clin Neuropharmacol 1999, 22:80-86.
35. Ortinski P., Kimford J.M. Cognitive side effects of antiepileptic drugs. Epilepsy Behav 2004, 5(Suppl. 1):60-65.
36. Palmer F.B., Yarworth S., Niedermeyer E. Frontal midline theta rhythm. Clin Electroencephalogr 1976, 7:131-138.
37. Park S.P., Kwon O.Y. Increased EEG current-source density in the high beta frequency band induced by levetiracetam adjunctive therapy in refractory partial epilepsy. J Clin Neurol 2009, 5:178-185.
38. Piazzini A., Chifari R., Canevini M.P., Turner K., Fontana S.P., Canger R. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy. Epilepsy Res 2006, 68:181-188.
39. Raven J., Raven J.C., Court J.H. Manual for Raven's progressive matrices and vocabulary scales 2003, Harcourt Assessment, San Antonio, TX.
40. Ray W.J., Cole H.W. EEG alpha activity reflects attentional demands, and beta activity reflects emotional and cognitive processes. Science 1985, 228:750-752.
41. Reitan R.M. Trail making test: manual for administration and scoring 1992, Neuropsychology Press, Tucson AZ.
42. Rocamora R., Wagner K., Schulze-Bonhage A. Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy. Seizure 2006, 15:428-433.
43. Salinsky M.C., Binder L.M., Oken B.S., Storzbach D., Aron C.R., Dodrill C.B. Effects of gabapentine and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia 2002, 43:482-490.
44. Seo J.G., Lee D.I., Hwang Y.H., Lee H.W., Jung D.K., Suh C.K., et al. Comparison of cognitive effects of lamotrigine and oxcarbazepine in epilepsy patients. J Clin Neurol 2007, 3:31-37.
45. Smith M.E., Gevins A., McEvoy L.K., Meador K.J., Ray P.G., Gilliam F. Distinct cognitive neurophysiologic profiles for lamotrigine and topiramate. Epilepsia 2006, 47:695-703.
46. Veauthier J., Haettig H., Meencke H.J. Impact of levetiracetam add-on therapy on different EEG occipital frequencies in epileptic patients. Seizure 2009, 18:392-395.
47. Wechlser D. Wechsler memory scale - Revised manual 1987, The Psychological Corporation, San Antonio, TX.
48. Zhou B., Zhang Q., Tian L., Xiao J., Stefan H., Zhou D. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures. Epilepsy Behav 2008, 12:305-310.